Genfit SA is a France-based biopharmaceutical company focused on the discovery and development of therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, particularly due to a lack of approved treatments. The Company provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The Company leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.
公司代码GNFT
公司名称Genfit SA
上市日期Dec 19, 2006
CEOPrigent (Pascal)
员工数量180
证券类型Depository Receipt
年结日Dec 19
公司地址Parc Eurasante 885 avenue Eugene Avinee
城市LOOS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家France
邮编59120
电话33320164000
网址https://www.genfit.fr/
公司代码GNFT
上市日期Dec 19, 2006
CEOPrigent (Pascal)